GW28-e0756 New and Definitive Marker Confirming the Optimal Status in the Treatment of Heart Failure with Preserved Ejection Fraction

At the present time, there is no criterion to estimate the optimal treatment for heart failure (HF) with preserved ejection fraction (HFpEF). In the past, our group suggested the criteria for diagnosis of HFpEF with normal EF and fluid overload using the size of the femoral vein (FV), measured by